IMCD N.V.
29.7.2026 07:00:00 CEST | Globenewswire | Press release
IMCD reports EBITA of EUR 285 million (+4%) in the first half of 2026
IMCD reports EBITA of EUR 285 million (+4%) in the first half of 2026
Rotterdam, The Netherlands (29 July 2026) - IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces its first half 2026 results.
HIGHLIGHTS
- Revenue at EUR 2,638 million (+11% on a constant currency basis)
- Gross profit at EUR 658 million (+7% on a constant currency basis)
- Operating EBITA at EUR 285 million (+8% on a constant currency basis)
- Free cash flow up by 29% to EUR 222 million (first half 2025: EUR 173 million)
- Cash earnings per share at EUR 3.18 (first half 2025: EUR 2.94)
- Completion of Dong Yang FT (South Korea) and Willows Ingredients (Ireland/UK) acquisitions, with Merit Solution (Thailand) agreement signed
Marcus Jordan, CEO: "We have had a positive first half of the year, achieving gross profit and EBITA organic growth alongside increased free cash flow generation. I'm proud of how our teams navigate the dynamic environment whilst maintaining a sharp focus on building long-term partnerships with both our customers and suppliers. We continue to drive forward our commercial, operational and digital excellence initiatives and remain firmly committed to generating long-term value for all stakeholders."
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
German High Street Properties A/S29.7.2026 08:07:00 CEST | Press release
Value adjustment of properties
Sanoma Corp29.7.2026 07:30:00 CEST | Press release
Sanoma Corporation, Half-Year Report 1 January–30 June 2026: Solid first six months
Basilea Pharmaceutica International Ltd, Allschwil29.7.2026 07:15:00 CEST | Press release
Basilea receives USD 30 million funding under existing BARDA agreement for advancing phase 3 development of novel antifungal fosmanogepix
Ascom Holding AG29.7.2026 07:00:00 CEST | Press release
Ascom reports significant increase in order intake in the first half of 2026 and improved profitability
Solvay S.A.29.7.2026 07:00:00 CEST | Press release
Solvay second quarter 2026 results
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom